Delta-Fly Pharma
4598.TTSE GROWTHPharmaceutical
Filed as Delta-Fly Pharma,Inc. (2022-06–2026-06)
Major holders (5%+) · 4
| Holder | Stake |
|---|---|
| Evo Fund | 16.03% |
| SBI SECURITIES Co., Ltd. | 8.45% |
| Kiyoshi Eshima | 6.18% |
| Arcus Investment Limited Director/Executive Director Edward Cartwright | 5.20% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 8
| Morgan Stanley MUFG Securities Co., Ltd. | 3.90% |
| J.P. Morgan Securities LLC | 2.00% |
| JPMorgan Securities Japan Co., Ltd. | 0.54% |
| J.P. Morgan Securities plc | 0.46% |
| Kyoko Eshima | 0.21% |
| J.P. Morgan Prime Inc. | 0.06% |
| Evolution Capital Management LLC | 0.00% |
| Macquarie Bank Limited | 0.00% |
Ownership history · 65
| Holder | Ratio | Change |
|---|---|---|
| SBI SECURITIES Co., Ltd.2026-09-25 | 8.45% | +3.46pp |
| Arcus Investment Limited Director/Executive Director Edward Cartwright2026-09-08 | 5.20% | new |
| Evolution Capital Management LLC2026-08-17 · amended | 0.00% | no change |
| Evo Fund2026-08-17 · amended | 22.71% | -9.40pp |
| Evolution Capital Management LLC2026-08-17 · amended | 0.00% | no change |
| Evo Fund2026-08-17 · amended | 32.11% | -1.28pp |
| Evolution Capital Management LLC2026-08-17 · amended | 0.00% | no change |
| Evo Fund2026-08-17 · amended | 33.39% | -8.58pp |
| Evolution Capital Management LLC2026-08-17 · amended | 0.00% | new |
| Evo Fund2026-08-17 · amended | 41.97% | new |
| Kiyoshi Eshima2026-07-30 · amended | 6.18% | -1.08pp |
| Morgan Stanley MUFG Securities Co., Ltd.2026-06-19 · amended | 3.90% | new |
| Kyoko Eshima2026-01-26 | 0.21% | -0.05pp |
| Kiyoshi Eshima2026-01-26 | 7.26% | -1.80pp |
| SBI SECURITIES Co., Ltd.2026-01-08 | 4.99% | -0.05pp |
| SBI SECURITIES Co., Ltd.2025-12-19 | 5.04% | +0.31pp |
| SBI SECURITIES Co., Ltd.2025-12-04 | 4.73% | -1.54pp |
| SBI SECURITIES Co., Ltd.2025-11-07 | 6.27% | +0.35pp |
| SBI SECURITIES Co., Ltd.2025-10-21 | 5.92% | +0.68pp |
| SBI SECURITIES Co., Ltd.2025-10-07 | 5.24% | +0.78pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.